ResMed Surges But Hits A Ceiling As The Battle With Weight-Loss Drugs RagesInvestors Business Daily • 01/25/24
ResMed (RMD) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 01/25/24
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 12/27/23
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical DevicesGlobeNewsWire • 12/20/23
ResMed Secures Significant Victory in Patent Fight Against New York UniversityGlobeNewsWire • 12/11/23
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients GloballyGlobeNewsWire • 12/07/23